Deferred Tax Assets, Valuation Allowance of BIOMARIN PHARMACEUTICAL INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • BIOMARIN PHARMACEUTICAL INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $181,743,000, a 44% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $181,743,000 +$55,432,000 +44% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $126,311,000 +$7,081,000 +5.9% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $119,230,000 +$2,931,000 +2.5% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q4 2022 $116,299,000 +$7,123,000 +6.5% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q4 2021 $109,176,000 +$16,101,000 +17% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q4 2020 $93,075,000 +$6,878,000 +8% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q4 2019 $86,197,000 -$21,731,000 -20% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $107,928,000 -$3,073,000 -2.8% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $111,001,000 +$37,964,000 +52% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $73,037,000 +$5,329,000 +7.9% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q4 2015 $67,708,000 +$59,896,000 +767% 31 Dec 2015 10-K 27 Feb 2017 2016 FY
Q4 2014 $7,812,000 -$535,000 -6.4% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q4 2013 $8,347,000 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q4 2010 $230,600,000 31 Dec 2010 10-K 22 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.